INIT / USDT

INIT / USDC

INIT / TRY

SAGA / BTC

SAGA / TRY

SAGA / USDC

SAGA / USDT

SAGA / FDUSD

ATM / TRY

ATM / USDT

OG / USDT

OG / TRY

币安人生 / TRY

PENGU / USDT

PENGU / USDC

FLOKI / IDR

PENGU / TRY

WIF / EUR

WIF / IDR

TURBO / USDT

GE POWER INDIA LIMITED

UNIVERSUS IMAGINGS LTD

SHANTHALA FMCG PRODUCTS L

USHANTI COLOUR CHEM LTD

INDIA VIX

REPRO INDIA LIMITED

DIVGI TORQTRANSFER SYST L

SRIVARI SPICES N FOODS L

ANMOL INDIA LIMITED

DC INFOTECH AND COMUN LTD

DELPHI WORLD MONEY LTD

QUANTUM NIFTY 50 ETF

PRANIK LOGISTICS LIMITED

CROWN LIFTERS LIMITED

MUTHOOT FINANCE LIMITED

RUCHIRA PAPERS LIMITED

ASIAN HOTELS (NORTH) LTD

COHANCE LIFESCIENCES LTD

GVP INFOTECH LIMITED

GENESYS INTL CORPN LTD

Click here to get full coverage on Tatva Chintan Pharma Chem Schedules Investor Meeting with Sequent Investments - MSN

Tatva Chintan Pharma Chem Schedules Investor Meeting with Sequent Investments  MSN

Tatva Chintan Pharma Chem Schedules Investor Meeting with Sequent Investments - MSN

Click here to get full coverage on Tatva Cafe serves vegetarian Indian cuisine in Ellisville - Sauce Magazine

Tatva Cafe serves vegetarian Indian cuisine in Ellisville  Sauce Magazine

Tatva Cafe serves vegetarian Indian cuisine in Ellisville - Sauce Magazine

Click here to get full coverage on Tatva Chintan Publishes Q3 FY26 Earnings Call Transcript for Investor Access - TipRanks

Tatva Chintan Publishes Q3 FY26 Earnings Call Transcript for Investor Access  TipRanks

Tatva Chintan Publishes Q3 FY26 Earnings Call Transcript for Investor Access - TipRanks

Click here to get full coverage on Tatva Hemal Damania and Shrushti Mahesh Taori | Maharashtra National Law University Archives - Jurist.org

Tatva Hemal Damania and Shrushti Mahesh Taori | Maharashtra National Law University Archives  Jurist.org

Tatva Hemal Damania and Shrushti Mahesh Taori | Maharashtra National Law University Archives - Jurist.org

Click here to get full coverage on Our 5 favorite Pittsburgh area restaurants that opened in 2025 - NEXTpittsburgh

Our 5 favorite Pittsburgh area restaurants that opened in 2025  NEXTpittsburgh

Our 5 favorite Pittsburgh area restaurants that opened in 2025 - NEXTpittsburgh

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd is Rated Hold - Markets Mojo

Tatva Chintan Pharma Chem Ltd is Rated Hold  Markets Mojo

Tatva Chintan Pharma Chem Ltd is Rated Hold - Markets Mojo

Click here to get full coverage on Inside Tatva Healthcare’s Purpose-Driven Mission to Build India’s Most Trusted Wellness Brand - Sangri Today

Inside Tatva Healthcare’s Purpose-Driven Mission to Build India’s Most Trusted Wellness Brand  Sangri Today

Inside Tatva Healthcare’s Purpose-Driven Mission to Build India’s Most Trusted Wellness Brand - Sangri Today

Click here to get full coverage on Market Participants Recognise Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Revenues Pushing Shares 34% Higher - simplywall.st

Market Participants Recognise Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Revenues Pushing Shares 34% Higher  simplywall.st

Market Participants Recognise Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Revenues Pushing Shares 34% Higher - simplywall.st

Click here to get full coverage on Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth - Business Standard

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth  Business Standard

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth - Business Standard

Click here to get full coverage on Tatva Legal Hyderabad rebrands as TLH Advocates & Solicitors - Law.asia

Tatva Legal Hyderabad rebrands as TLH Advocates & Solicitors  Law.asia

Tatva Legal Hyderabad rebrands as TLH Advocates & Solicitors - Law.asia

Click here to get full coverage on Tatva Chintan Pharma Files SEBI Takeover Disclosure for Promoter Share Transfer - scanx.trade

Tatva Chintan Pharma Files SEBI Takeover Disclosure for Promoter Share Transfer  scanx.trade

Tatva Chintan Pharma Files SEBI Takeover Disclosure for Promoter Share Transfer - scanx.trade

Click here to get full coverage on Reduce Tatva Chintan Pharma Chem; target of Rs 1380: Deven Choksey - Moneycontrol

Reduce Tatva Chintan Pharma Chem; target of Rs 1380: Deven Choksey  Moneycontrol

Reduce Tatva Chintan Pharma Chem; target of Rs 1380: Deven Choksey - Moneycontrol

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Hits Intraday High with 7.51% Surge on 9 Feb 2026 - Markets Mojo

Tatva Chintan Pharma Chem Ltd Hits Intraday High with 7.51% Surge on 9 Feb 2026  Markets Mojo

Tatva Chintan Pharma Chem Ltd Hits Intraday High with 7.51% Surge on 9 Feb 2026 - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Limited Just Beat EPS By 44%: Here's What Analysts Think Will Happen Next - simplywall.st

Tatva Chintan Pharma Chem Limited Just Beat EPS By 44%: Here's What Analysts Think Will Happen Next  simplywall.st

Tatva Chintan Pharma Chem Limited Just Beat EPS By 44%: Here's What Analysts Think Will Happen Next - simplywall.st

Click here to get full coverage on This chemical stock defies market crash, zooms 20%; here's why - MSN

This chemical stock defies market crash, zooms 20%; here's why  MSN

This chemical stock defies market crash, zooms 20%; here's why - MSN

Click here to get full coverage on Tatva Chintan Pharma Chem Limited's (NSE:TATVA) most bullish insider is Senior Key Executive Ajaykumar Patel, and their holdings value went up by 10% last week - simplywall.st

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) most bullish insider is Senior Key Executive Ajaykumar Patel, and their holdings value went up by 10% last week  simplywall.st

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) most bullish insider is Senior Key Executive Ajaykumar Patel, and their holdings value went up by 10% last week - simplywall.st

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure - Markets Mojo

Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure  Markets Mojo

Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - simplywall.st

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?  simplywall.st

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - simplywall.st

Click here to get full coverage on Ajay Mansukhlal Patel to Acquire 7,15,345 Equity Shares in Tatva Chintan Pharma Chem Through HUF Dissolution - scanx.trade

Ajay Mansukhlal Patel to Acquire 7,15,345 Equity Shares in Tatva Chintan Pharma Chem Through HUF Dissolution  scanx.trade

Ajay Mansukhlal Patel to Acquire 7,15,345 Equity Shares in Tatva Chintan Pharma Chem Through HUF Dissolution - scanx.trade

Click here to get full coverage on Briefs: Tatva Chintan Pharma Chem and Shelter Pharma - Indian Pharma Post

Briefs: Tatva Chintan Pharma Chem and Shelter Pharma  Indian Pharma Post

Briefs: Tatva Chintan Pharma Chem and Shelter Pharma - Indian Pharma Post

Click here to get full coverage on TLH expands disputes offerings with senior in-house hire - ETLegalWorld.com

TLH expands disputes offerings with senior in-house hire  ETLegalWorld.com

TLH expands disputes offerings with senior in-house hire - ETLegalWorld.com

Click here to get full coverage on Tatva Chintan Consolidated December 2025 Net Sales at Rs 131.33 crore, up 52.9% Y-o-Y - Moneycontrol

Tatva Chintan Consolidated December 2025 Net Sales at Rs 131.33 crore, up 52.9% Y-o-Y  Moneycontrol

Tatva Chintan Consolidated December 2025 Net Sales at Rs 131.33 crore, up 52.9% Y-o-Y - Moneycontrol

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Hits Intraday High with 8.62% Surge on 3 Feb 2026 - Markets Mojo

Tatva Chintan Pharma Chem Ltd Hits Intraday High with 8.62% Surge on 3 Feb 2026  Markets Mojo

Tatva Chintan Pharma Chem Ltd Hits Intraday High with 8.62% Surge on 3 Feb 2026 - Markets Mojo

Click here to get full coverage on Tatva Chintan Standalone December 2025 Net Sales at Rs 138.59 crore, up 64.99% Y-o-Y - Moneycontrol

Tatva Chintan Standalone December 2025 Net Sales at Rs 138.59 crore, up 64.99% Y-o-Y  Moneycontrol

Tatva Chintan Standalone December 2025 Net Sales at Rs 138.59 crore, up 64.99% Y-o-Y - Moneycontrol

Click here to get full coverage on Tatva Legal Hyderabad rebrands as TLH, Advocates & Solicitors - BW Legal World

Tatva Legal Hyderabad rebrands as TLH, Advocates & Solicitors  BW Legal World

Tatva Legal Hyderabad rebrands as TLH, Advocates & Solicitors - BW Legal World

Click here to get full coverage on Here's why Tatva Chintan Pharma shares surged 20% on Friday in a weak market - CNBC TV18

Here's why Tatva Chintan Pharma shares surged 20% on Friday in a weak market  CNBC TV18

Here's why Tatva Chintan Pharma shares surged 20% on Friday in a weak market - CNBC TV18

Click here to get full coverage on Excentia Infra Launches Phase 2 of Excentia Tatva, Dehraduns Ultra-Luxury Landmark - Tribune India

Excentia Infra Launches Phase 2 of Excentia Tatva, Dehraduns Ultra-Luxury Landmark  Tribune India

Excentia Infra Launches Phase 2 of Excentia Tatva, Dehraduns Ultra-Luxury Landmark - Tribune India

Click here to get full coverage on Tatva Chintan Consolidated June 2025 Net Sales at Rs 116.86 crore, up 10.81% Y-o-Y - Moneycontrol

Tatva Chintan Consolidated June 2025 Net Sales at Rs 116.86 crore, up 10.81% Y-o-Y  Moneycontrol

Tatva Chintan Consolidated June 2025 Net Sales at Rs 116.86 crore, up 10.81% Y-o-Y - Moneycontrol

Click here to get full coverage on Buy Tatva Chintan Pharma Chem; target of Rs 1955: ICICI Securities - Moneycontrol

Buy Tatva Chintan Pharma Chem; target of Rs 1955: ICICI Securities  Moneycontrol

Buy Tatva Chintan Pharma Chem; target of Rs 1955: ICICI Securities - Moneycontrol

Click here to get full coverage on Sell Tatva Chintan Pharma Chem; target of Rs 860: Deven Choksey - Moneycontrol

Sell Tatva Chintan Pharma Chem; target of Rs 860: Deven Choksey  Moneycontrol

Sell Tatva Chintan Pharma Chem; target of Rs 860: Deven Choksey - Moneycontrol

Click here to get full coverage on Shashank Nimkar on Earth Tatva: Turning Ceramic Waste Into Sustainable Design - The Hindu

Shashank Nimkar on Earth Tatva: Turning Ceramic Waste Into Sustainable Design  The Hindu

Shashank Nimkar on Earth Tatva: Turning Ceramic Waste Into Sustainable Design - The Hindu

Click here to get full coverage on Tatva Chintan Pharma Chem Targets 20-30% Revenue Growth for FY26 and FY27 - scanx.trade

Tatva Chintan Pharma Chem Targets 20-30% Revenue Growth for FY26 and FY27  scanx.trade

Tatva Chintan Pharma Chem Targets 20-30% Revenue Growth for FY26 and FY27 - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem: Analytical Perspective Shift Amid Mixed Financial and Technical Signals - Markets Mojo

Tatva Chintan Pharma Chem: Analytical Perspective Shift Amid Mixed Financial and Technical Signals  Markets Mojo

Tatva Chintan Pharma Chem: Analytical Perspective Shift Amid Mixed Financial and Technical Signals - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem reports consolidated Q4 FY25 PAT at Rs. 1.03 Cr - Indian Pharma Post

Tatva Chintan Pharma Chem reports consolidated Q4 FY25 PAT at Rs. 1.03 Cr  Indian Pharma Post

Tatva Chintan Pharma Chem reports consolidated Q4 FY25 PAT at Rs. 1.03 Cr - Indian Pharma Post

Click here to get full coverage on Tatva Chintan Pharma Chem Targets 20-22% EBITDA Margins by FY27 Through Enhanced Plant Utilization - scanx.trade

Tatva Chintan Pharma Chem Targets 20-22% EBITDA Margins by FY27 Through Enhanced Plant Utilization  scanx.trade

Tatva Chintan Pharma Chem Targets 20-22% EBITDA Margins by FY27 Through Enhanced Plant Utilization - scanx.trade

Click here to get full coverage on Tatva Chintan Consolidated September 2025 Net Sales at Rs 123.52 crore, up 47.94% Y-o-Y - Moneycontrol

Tatva Chintan Consolidated September 2025 Net Sales at Rs 123.52 crore, up 47.94% Y-o-Y  Moneycontrol

Tatva Chintan Consolidated September 2025 Net Sales at Rs 123.52 crore, up 47.94% Y-o-Y - Moneycontrol

Click here to get full coverage on Tatva Chintan Pharma Chem Projects ₹200-250 Crores Revenue from New Intermediates by 2027 - scanx.trade

Tatva Chintan Pharma Chem Projects ₹200-250 Crores Revenue from New Intermediates by 2027  scanx.trade

Tatva Chintan Pharma Chem Projects ₹200-250 Crores Revenue from New Intermediates by 2027 - scanx.trade

Click here to get full coverage on Mukul Agrawal portfolio stock up 87% from April; what's behind the rally? - Business Standard

Mukul Agrawal portfolio stock up 87% from April; what's behind the rally?  Business Standard

Mukul Agrawal portfolio stock up 87% from April; what's behind the rally? - Business Standard

Click here to get full coverage on Tatva Chintan Pharma Chem (NSE:TATVA) Will Be Hoping To Turn Its Returns On Capital Around - simplywall.st

Tatva Chintan Pharma Chem (NSE:TATVA) Will Be Hoping To Turn Its Returns On Capital Around  simplywall.st

Tatva Chintan Pharma Chem (NSE:TATVA) Will Be Hoping To Turn Its Returns On Capital Around - simplywall.st

Click here to get full coverage on Tatva Chintan Pharma Chem Projects ₹850-900 Crores Revenue from Current Capacity - scanx.trade

Tatva Chintan Pharma Chem Projects ₹850-900 Crores Revenue from Current Capacity  scanx.trade

Tatva Chintan Pharma Chem Projects ₹850-900 Crores Revenue from Current Capacity - scanx.trade

Click here to get full coverage on Mukul Agrawal buys stake in this underperforming IPO, sends stock soaring - CNBC TV18

Mukul Agrawal buys stake in this underperforming IPO, sends stock soaring  CNBC TV18

Mukul Agrawal buys stake in this underperforming IPO, sends stock soaring - CNBC TV18

Click here to get full coverage on Tatva Chintan Pharma drops on profit booking - Business Standard

Tatva Chintan Pharma drops on profit booking  Business Standard

Tatva Chintan Pharma drops on profit booking - Business Standard

Click here to get full coverage on Tatva Chintan Pharma Chem Hits New 52-Week High at Rs. 1232.65 - Markets Mojo

Tatva Chintan Pharma Chem Hits New 52-Week High at Rs. 1232.65  Markets Mojo

Tatva Chintan Pharma Chem Hits New 52-Week High at Rs. 1232.65 - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Reports Outstanding Quarterly Financial Performance Amid Shifting Market Trends - Markets Mojo

Tatva Chintan Pharma Chem Ltd Reports Outstanding Quarterly Financial Performance Amid Shifting Market Trends  Markets Mojo

Tatva Chintan Pharma Chem Ltd Reports Outstanding Quarterly Financial Performance Amid Shifting Market Trends - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Hits New 52-Week High of Rs. 1341.1 - Markets Mojo

Tatva Chintan Pharma Chem Hits New 52-Week High of Rs. 1341.1  Markets Mojo

Tatva Chintan Pharma Chem Hits New 52-Week High of Rs. 1341.1 - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Announces ₹250-275 Crore Greenfield Plant at Jolva - scanx.trade

Tatva Chintan Pharma Chem Announces ₹250-275 Crore Greenfield Plant at Jolva  scanx.trade

Tatva Chintan Pharma Chem Announces ₹250-275 Crore Greenfield Plant at Jolva - scanx.trade

Click here to get full coverage on Mukul Agrawal picks 1.28% stake in this underperforming stock, drives 14% surge - The Economic Times

Mukul Agrawal picks 1.28% stake in this underperforming stock, drives 14% surge  The Economic Times

Mukul Agrawal picks 1.28% stake in this underperforming stock, drives 14% surge - The Economic Times

Click here to get full coverage on Tatva Chintan Pharma shares in focus after CRISIL downgrades ratings on bank facilities - CNBC TV18

Tatva Chintan Pharma shares in focus after CRISIL downgrades ratings on bank facilities  CNBC TV18

Tatva Chintan Pharma shares in focus after CRISIL downgrades ratings on bank facilities - CNBC TV18

Click here to get full coverage on Tatva Chintan Pharma Chem: Specialty Chemicals Play Poised for Recovery after Downcycle - Moneylife

Tatva Chintan Pharma Chem: Specialty Chemicals Play Poised for Recovery after Downcycle  Moneylife

Tatva Chintan Pharma Chem: Specialty Chemicals Play Poised for Recovery after Downcycle - Moneylife

Click here to get full coverage on Tatva Chintan Pharma Chem Hits Day High with 7.92% Surge - Markets Mojo

Tatva Chintan Pharma Chem Hits Day High with 7.92% Surge  Markets Mojo

Tatva Chintan Pharma Chem Hits Day High with 7.92% Surge - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Hits New 52-Week High at Rs. 1448.45 - Markets Mojo

Tatva Chintan Pharma Chem Hits New 52-Week High at Rs. 1448.45  Markets Mojo

Tatva Chintan Pharma Chem Hits New 52-Week High at Rs. 1448.45 - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Surges 14% as Mukul Agrawal Acquires 1.28% Stake - scanx.trade

Tatva Chintan Pharma Chem Surges 14% as Mukul Agrawal Acquires 1.28% Stake  scanx.trade

Tatva Chintan Pharma Chem Surges 14% as Mukul Agrawal Acquires 1.28% Stake - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Shows Bullish Momentum Amid Technical Shifts - Markets Mojo

Tatva Chintan Pharma Chem Shows Bullish Momentum Amid Technical Shifts  Markets Mojo

Tatva Chintan Pharma Chem Shows Bullish Momentum Amid Technical Shifts - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Hits New 52-Week High of Rs. 1543.05 - Markets Mojo

Tatva Chintan Pharma Chem Hits New 52-Week High of Rs. 1543.05  Markets Mojo

TATVA

Price Chart

Key Statistics

Technicals

About TATVA

Latest News

Tatva Chintan Pharma Chem Schedules Investor Meeting with Sequent Investments - MSN

Tatva Cafe serves vegetarian Indian cuisine in Ellisville - Sauce Magazine

Tatva Chintan Publishes Q3 FY26 Earnings Call Transcript for Investor Access - TipRanks

Advanced Charts

Top Gainers

Top Losers